Last reviewed · How we verify
NCT00339794
Clinical Integration of Genetic Risk Assessment in Family Medicine
trial in Genomics in 1,500 participants. Completed in 16 July 2010.
Quick facts
| Lead sponsor | National Human Genome Research Institute (NHGRI) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 7 December 2004 |
| Estimated completion | 16 July 2010 |
| Sites | 1 location across United States |
Conditions studied
- Genomics — all drugs for Genomics →
Sponsor
National Human Genome Research Institute (NHGRI)
Who can join
21 and older, any sex, with Genomics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study, conducted by the American Academy of Family Physicians (AAFP) and the National Human Genome Research Institute, will characterize family physicians' attitudes and practices related to the genetics of complex disorders. As the front line of care for most Americans, family medicine will have a central role in seeing that new findings in genetics lead to disease prevention and health improvements. The information gained from this study could be useful in understanding and shaping the dissemination of genetic medicine in ways that improve the standard of primary care practice. Members of the AAFP will be randomly selected from the organization's membership records to be invited to participate in this two-phase study. The first phase is a web-based survey of AAFP members. In the second phase, a sub-sample of those who complete the survey will be re-contacted; half will be members who have enrolled in a year-long web-based curriculum related to medical genetics, and the other half will be those who have chosen not to enroll in the curriculum. Survey questions relate to the physicians' practices, knowledge, and opinions about implications of genomic medicine. Survey areas include family history taking; opinions about the future of genetics and family medicine; information about the physician and his or her practice; and physician's skills, attitudes and knowledge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00339794
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Genomics
Currently open trials in the same condition.
- NCT06614660 — Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer · active not recruiting
Other National Human Genome Research Institute (NHGRI) trials
Trials by the same sponsor.
- NCT05657405 — Observational Study of Advanced Data Analytics in Genetic Conditions · recruiting
- NCT06948110 — Deciphering the Genetic Architecture of Autoimmune Diseases · recruiting
- NCT06664814 — An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomeruloscleros · Phase 2 · recruiting
- NCT06595940 — Genetic Analysis of Uncommon Disease Presentations in Non-US Populations · recruiting
- NCT06552754 — Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00339794 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Human Genome Research Institute (NHGRI)
- Last refreshed: 2 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00339794.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing